| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-11 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-07 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.22 | 3e-06 |